Scotts Miracle-Gro Chief Strategy Officer Christopher Hagedorn transacted 4 shares at $53.41 per share on Aug. 31, 2026. Hagedorn then owned 57,556 shares, while the transaction represented about 0.0% of his resulting holding. The reported figures show the transaction was small relative to his post-transaction position.
Key Highlights
- Christopher Hagedorn held 57,556 Scotts Miracle-Gro shares after the transaction.
- The transaction occurred on Aug. 31, 2026, under transaction code J.
- The 4-share transaction represented about 0.0% of Hagedorn’s resulting holding.
SCOTTS MIRACLE-GRO CO (NYSE: SMG) recorded a 4-share transaction by Chief Strategy Officer Christopher Hagedorn at $53.41 per share. The transaction was dated Aug. 31, 2026.
Hagedorn’s Post-Transaction Position
Hagedorn serves as Scotts Miracle-Gro’s executive vice president and chief strategy officer. The transaction carried code J. His reported position after the transaction was 57,556 shares. The transaction’s stated price was $53.41 for each share involved. The reported activity covered 4 shares of Scotts Miracle-Gro.
Transaction Size Relative to Holdings
The 4-share transaction represented about 0.0% of Hagedorn’s resulting shareholding. That percentage is measured against the 57,556 shares he owned after the transaction.
FAQs
Q: What was Christopher Hagedorn’s Scotts Miracle-Gro transaction?
A: Christopher Hagedorn transacted 4 Scotts Miracle-Gro shares at $53.41 per share on Aug. 31, 2026. The transaction used code J.
Q: How many SMG shares did Hagedorn own afterward?
A: Christopher Hagedorn owned 57,556 Scotts Miracle-Gro shares after the reported transaction. He is the company’s executive vice president and chief strategy officer.
Q: What percentage of Hagedorn’s holding did the transaction represent?
A: The filing stated that the transaction represented about 0.0% of his resulting shares holding. That resulting holding was 57,556 shares after the transaction.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.